Follow-On Biologics Could Gain From “Bolar Amendment” Ruling – Attorney
Executive Summary
A Supreme Court ruling that extends "Bolar Amendment" protection to preclinical research on new drug candidates could aid the development of follow-on biologics, attorney Kathleen Madden Williams (Palmer & Dodge) said